HQ Function

Served as the central hub for corporate administration, research and development leadership, clinical operations, and strategic planning for AvroBio's gene therapy programs.

Notable Features:

The headquarters housed state-of-the-art laboratory facilities for cell processing, analytical development, and translational research. Its location in Kendall Square provided proximity to leading academic institutions, research organizations, and other biotech companies.

Work Culture:

AvroBio's work culture was characterized by a patient-centric, science-driven, and collaborative environment. Employees were passionate about advancing gene therapies for rare diseases, working in a dynamic and innovative setting.

HQ Significance:

The Cambridge HQ was pivotal for AvroBio, offering access to a rich talent pool, cutting-edge research collaborations (e.g., with MIT and Harvard affiliates), and a strong venture capital and biopharma network, all essential for a developing gene therapy company.

Values Reflected in HQ: The headquarters' location and facilities mirrored AvroBio's core values of scientific excellence, innovation in gene therapy, a strong commitment to patients with rare diseases, and collaboration within the biotech ecosystem.

Location:

While headquartered in Cambridge, MA, USA, AVROBIO had a global operational footprint. Its clinical trials for various gene therapies were conducted across multiple countries in North America, Europe, and Australia to reach diverse patient populations. The company also had early research and development operations in Toronto, Canada, and established a dedicated cGMP viral vector manufacturing facility in Durham, North Carolina, USA, to support its clinical programs worldwide.

Street Address:

One Kendall Square, Building 300, Suite 201

City:

Cambridge

State/Province:

MA

Country:

USA